⌘K

Login Start Free

Home/Filings/4/0001104659-22-121618

4//SEC Filing

MARGOLIN YAEL 4

Accession 0001104659-22-121618

CIK 0001811764other

View on SEC.gov Company Profile

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 12:43 PM ET

Size

4.5 KB

Accession

0001104659-22-121618

Insider Transaction Report

Form 4

Period: 2022-11-21

POINT Biopharma Global Inc.PNT

Director

Transactions

Purchase
Common Stock
2022-11-21$6.56/sh+1,710$11,218→ 1,710 total

Documents

1 file

4
tm2231289-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

POINT Biopharma Global Inc.

CIK 0001811764

Entity typeother

Related Parties

1

filerCIK 0001868637

Filing Metadata

Form type: 4
Filed: Nov 22, 7:00 PM ET
Accepted: Nov 23, 12:43 PM ET
Size: 4.5 KB

View on SEC.gov